(Q40148472)

17 September 2017

title

Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma (English)

1 reference

17 September 2017

Wu A

1

1 reference

17 September 2017

Oh S

2

1 reference

17 September 2017

Ericson K

3

1 reference

17 September 2017

Demorest ZL

4

1 reference

17 September 2017

Vengco I

5

1 reference

17 September 2017

Gharagozlou S

6

1 reference

17 September 2017

Chen W

7

1 reference

17 September 2017

Low WC

8

1 reference

17 September 2017

Ohlfest JR

9

1 reference

17 September 2017

publication date

6 April 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

14

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

550-560

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701045

17 September 2017

exact match

0 references

cites work

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

Intracisternally localized bacterial DNA containing CpG motifs induces meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: dependence on apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

Potential of gene therapy for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Gene therapy and targeted toxins for glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Sleeping beauty transposition: biology and applications for molecular therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Role of interferon-gamma in immune cell regulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Cytokine therapy in dermatology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Gene transfer into genomes of human cells by the sleeping beauty transposon system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Development of hyperactive sleeping beauty transposon vectors by mutational analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Hyperactive transposase mutants of the Sleeping Beauty transposon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Phage integrases: biology and applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Transposons for gene therapy!

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701045

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701045

1 reference

Dimensions Publication ID

17 September 2017

1032230003

0 references

1 reference